Carcinoembryonic antigen-related cell adhesion molecule 5 (568-582)

Carcinoembryonic antigen-related cell adhesion molecule 5

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: ta-245

Synonyms/Alias:Carcinoembryonic antigen-related cell adhesion molecule 5 (568-582)

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
Sequence
AYVCGIQNSVSANRS
Areas of Interest
Antigen-presenting Cells; Cancer Research

Carcinoembryonic antigen-related cell adhesion molecule 5 (568-582) is a synthetic peptide fragment derived from the larger CEACAM5 protein, a member of the carcinoembryonic antigen (CEA) family known for its involvement in cell adhesion, intracellular signaling, and modulation of immune responses. This specific segment, encompassing residues 568 to 582, has attracted significant interest in the biochemical and molecular biology research communities due to its relevance in the structural and functional analysis of CEACAM5 and its role in mediating cell-cell interactions. As a defined peptide epitope, it offers a valuable tool for dissecting the molecular mechanisms underpinning CEACAM5-mediated processes, particularly in the context of oncology, immunology, and cell signaling studies.

Epitope mapping: The peptide corresponding to residues 568-582 serves as a precise molecular probe for epitope mapping studies, enabling researchers to identify and characterize antibody binding sites on CEACAM5. This application is particularly relevant in the development and validation of monoclonal or polyclonal antibodies targeting specific regions of the protein. By employing the synthetic fragment in immunoassays such as ELISA or Western blot, investigators can delineate the antibody recognition landscape, facilitating the design of highly specific detection reagents for basic research or diagnostic development.

Protein-protein interaction analysis: As a well-defined segment of the CEACAM5 extracellular domain, the peptide is instrumental in elucidating the molecular determinants of cell adhesion and signaling events mediated by this protein family. In vitro binding assays utilizing the 568-582 fragment can help clarify the interaction interfaces between CEACAM5 and its ligands or binding partners, including other cell adhesion molecules or regulatory proteins. Such studies contribute to a deeper understanding of the structural basis for cell-cell communication and the modulation of cellular responses in both normal physiology and pathological states.

Peptide-based assay development: The 568-582 peptide fragment is frequently incorporated into custom assay platforms designed to monitor CEACAM5-related biological activities. For example, it can serve as a standard or competitor in quantitative immunoassays, enabling accurate measurement of antibody affinity or specificity. Its defined sequence and biochemical stability make it well-suited for use in high-throughput screening protocols, where reproducible performance is essential for reliable data acquisition.

Immunological studies: Researchers investigating immune recognition mechanisms often utilize this peptide to probe T cell or B cell responses against CEACAM5-derived epitopes. By incorporating the fragment into ex vivo or in vitro immune assays, it is possible to assess antigen-specific cellular activation, cytokine production, or antibody generation. These studies are critical for advancing knowledge of immune surveillance, tolerance, and the potential for immune modulation in disease models where CEACAM5 is implicated.

Structural and functional analysis: The 568-582 region of CEACAM5 is of interest for structural biology investigations, including NMR spectroscopy or crystallography, to elucidate conformational properties and functional motifs within the protein. Synthetic peptides corresponding to this sequence can be used as models to study local secondary structure, post-translational modification sites, or interactions with small molecules. Such applications provide valuable insights into the mechanistic roles of specific CEACAM5 domains and inform the rational design of molecular probes or inhibitors for advanced research purposes.

Source#
Homo sapiens (human)
Epitope
568-582
Restricting HLA
HLA-DR3
References
Crosti; J Immunol 2006

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Epitope Mapping ServicesPeptide Synthesis ServicesPeptide CDMOCustom Conjugation ServicecGMP Peptide ServicePeptide Nucleic Acids SynthesisPeptide Modification ServicesPeptide Analysis Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers